>>> US Gapping down

Gapping down
In reaction to disappointing earnings/guidance
:
  • TISI -20.8%, (reports prelim Q2 results, finalizes negotiations of credit facility amendment and terminates At-the-Market equity offering program), STX -14.8%, MDR -12.6%, SANM -9.9%, CLB -6.1%, LOGI-6.1%, CRY -4.6%, EDU -4.3%, PCRX -4%, HSII -2.9%, GOOG -2.8%, APC-2.7%, MMM -2.4%, LPL -1.9%, LLY -1.5%, HXL -1.4%, CVLT -1.2%, DPZ-0.9%, WWD -0.6%
Other news:
  • NVAX -19.2% (announces'positive' topline data from its Phase 2 safety and immunogenicity trial of the RSV F Vaccine in older adults, new data on RSV F vaccine, and additional findings from prior phase 2 and 3 studies of E201 and E301)
  • FTI -7.7% (restates financial information due to calculations of foreign currency effects )
  • INCY -3.1% (Incyte and Eli Lilly (LLY) announces the resubmission to the FDA of the NDA for baricitinib)
  • WDC -2.9% (in sympathy with STX)
  • MU -2.3% (in sympathy with STX)
  • SLNO -1.2% (sells one of its non-strategic subsidiaries, NeoForce, Inc., which manufacturers and promotes a range of innovative pulmonary resuscitation solutions in the neonatal market, to Flexicare; terms not disclosed)
  • MBRX -1.1% (files for $75 mln mixed securities shelf offering)
  • SRPT -1.1% (prices 7.65 mln shares of common stock at $42.50 per share)
Analyst comments:
  • UAA -2.6% (downgraded to Sell at Deutsche Bank)

>>> US Gapping up

Gapping up
In reaction to strong earnings/guidance
:
  • DCIX +20.7%, PCAR +7%, CNC +5.7%, CAT +4.5%, BIIB +3.7%, JBLU +3%,RMBS +2.8%, CDNS +2.7%, ATI +2.7%, MCC +2.7%, PHM +2.4%, ST+2.1%, SWFT +1.9%, GM +1.9%, FCX +1.9%, MC +1.8%, VEDL +1.6%,UTX +1%, KMB +1%, NEM +0.9%, DD +0.8%, SVU +0.6%
M&A news:
  • KORS +3% (Michael Kors to acquire Jimmy Choo for $1.35 bln)
Other news:
  • GNCA +8.6% (continued strength)
  • CYRX +7.1% (CryoPort announces Novartis (NVS) has signed an agreement contracting Cryoport over an initial three-year term for cryogenic logistics support of CTL019/CD19 CAR-T cell therapy)
  • CGEN +5.9% (has been issued a U.S. patent for COM701)
  • CLLS +5.2% (granted patent for CRISPR use in CAR T-cells)
  • MDCO +4.8% (announces randomization in the TANGO-2 trial of its meropenem-vaborbactaml was stopped early, following a recommendation by the DSMB)
  • BCLI +2.5% (signs agreement with the University of California Irvine Medical Center to enroll patients in the planned Phase 3 clinical trial of NurOwn in ALS, pending FDA and Institutional Review Board approvals)
  • TEAR +2.1% (continued volatility in pre-mkt)
  • JCP +1.8% (announced that Jeffrey Davis is joining as EVP/CFO effective today)
  • JD +1.1% (s Walmart (WMT) and JD.com (JD) are expanding their cooperation to further integrate their platforms, supply chains and customer resources in China)
  • HAS +1% (CEO featured on Monday's Mad Money)
  • GRFS +0.8% (announces the acquisition of additional 40% stake in Kiro)
Analyst comments:
  • TNTR +7.1% (initiated with a Buy at BofA/Merrill, among others)
  • PLUG +2.1% ( target raised to $3.50 from $3 at FBR & Co)

Sky : Buyout firms spread load in £6bn Unilever bid

Buyout firms spread load in £6bn Unilever bid
CD&R and Bain Capital have formed a consortium to make an offer for the unit which holds Flora margarine, Sky News learns.

Two of the world’s biggest private equity groups have joined forces to assemble a knockout takeover bid for the £6bn Unilever division which houses the Flora margarine brand.

Sky News has learnt that Clayton Dubilier & Rice and Bain Capital have begun working together on an offer for the Anglo-Dutch consumer goods group's spreads business, which it has outlined plans to offload.

CD&R and Bain's partnership is the first significant bidding group to emerge after months of speculation about the likely participants in an auction of the unit, which also holds the I Can't Believe It's Not Butter brand.

Sources said that CD&R's interest would lean heavily on Vindi Banga, a former Unilever foods executive, and Sir Terry Leahy, the former boss of Tesco - both of whom are already closely involved with the buyout firm.

Bain, meanwhile, has significant experience of carving out complex business units from large multinationals, having reaped huge gains from its role in acquiring Worldpay, the payments business, from Royal Bank of Scotland.

Other consortia are expected to form over the summer as Unilever gets ready to sell the business, although it could opt to dispose of it through a demerger to its existing shareholders if offers are not sufficiently attractive.

Announcing half-year results last week, Paul Polman, Unilever's chief executive, said preparations for an auction were "well underway".

The intention to sell or demerge the spreads division came two months after Unilever was the subject of an unsolicited £115bn takeover approach from Kraft Heinz, the US-headquartered food giant.

The move from Kraft Heinz sparked a hostile reaction from the Unilever board and rang alarm bells in Downing Street, where Theresa May had vowed to clamp down on unwanted foreign takeovers.

Mr Polman, who said last week that Unilever was becoming a "more resilient, more competitive and more profitable" company, had called for a "level playing field" in response to the Kraft Heinz approach.

He later insisted that he was not calling for the Anglo-Dutch fast-moving consumer goods group to receive special protection from the Government.

In recent months, Unilever has been linked to a bid for the £3bn food unit of Reckitt Benckiser, which it agreed to sell last week to McCormick's of the US.

Mr Polman has also turned to faster-growing categories for takeover opportunities, snapping up the online-based Dollar Shave Club for $1bn last year.

The spreads category has been in long-term decline as increasingly health-conscious consumers have turned to butter-based products.

That trend reinforces the likelihood that

>>> McDonald's beats by $0.11, beats on revs (151.85)

McDonald's beats by $0.11, beats on revs (151.85)
  • Reports Q2 (Jun) earnings of $1.73 per share, $0.11 better than the Capital IQ Consensus of $1.62; revenues fell 3.4% year/year to $6.05 bln vs the $5.96 bln Capital IQ Consensus.
  • Global comparable sales increased 6.6% [vs. ests near +4%], reflecting positive guest counts in all segments
    • In the U.S., second quarter comparable sales increased 3.9%, reflecting the national cold beverage value promotion and the launch of the Signature Crafted premium sandwich platform. The U.S. continues to build momentum as it executes strategies to enhance convenience, strengthen value and innovate around the menu to bring more customers to McDonald's more often. Operating income for the quarter increased 5%, reflecting higher sales-driven franchised margin dollars, G&A savings and higher gains on sales of restaurants.
    • Comparable sales for the International Lead segment increased 6.3% for the quarter, led by continued momentum in the U.K., strong performance in Canada and Germany and positive results across all other markets. The segment's operating income increased 8% (13% in constant currencies), fueled primarily by sales-driven improvements in franchised margin dollars.
    • In the High Growth segment, second quarter comparable sales increased 7.0%, led by strong performance in China and positive results across the entire segment. The segment's operating income rose 28% (28% in constant currencies), with about half of the increase resulting from lower depreciation expense due to the accounting treatment related to the pending sale of the China and Hong Kong businesses.
    • In the Foundational Markets & Corporate segment, second quarter comparable sales rose 13.0% and operating income increased significantly, led by very strong performance in Japan as well as strong results across the segment's other geographic regions. The segment also benefited from comparison to the prior year's strategic charges.

FT : United Tech raises 2017 guidance as elevator and heating system sales climb

United Technologies has raised its 2017 sales and profits guidance as growth in its elevator and escalator business along with strong demand for its building heating and cooling systems helped boost second quarter results.

The US industrial conglomerate, which makes everything from jet engines to moving walkways, said it now expects organic sales to grow between 3-4 per cent this year, up from its previous forecast of 2-4 per cent growth.

Adjusted earnings per share meanwhile was projected to be $6.45-$6.60, compared to the $6.30-$6.60 range it was expecting.

The outlook upgrade comes as United Technologies delivered second quarter sales and profits that came in ahead of Wall Street estimates.

For the three months to end of June, sales rose nearly 3 per cent to $15.28bn, driven by gains in three of its four divisions. UTC climate, controls & security – the company’s biggest unit by revenue and which provides fire safety and security, building automation, heating and cooling and refrigeration systems and services, saw sales climb 5.6 per cent to $4.7bn during the period. Higher sales in its Otis elevator and Pratt & Whitney engine divisions all helped to offset continued sluggishness in United Technologies aerospace systems unit, where sales fell 2 per cent to $3.6bn.

Net income came in at $1.44bn, or $1.80 per diluted share.

Shares in United Technologies have gained more than 12 per cent this year amid a rebound in global growth and expectations that it would benefit from President Donald Trump’s promise to boost military spending. The stock hit a record high of $124.79 earlier this month and was trading 0.5 per cent lower in pre-market trading on Tuesday.

>>> Kimberly-Clark beats by $0.04, reports revs in-line; tempers FY17 guidance

Kimberly-Clark beats by $0.04, reports revs in-line; tempers FY17 guidance (123.81)
  • Reports Q2 (Jun) earnings of $1.53 per share, $0.04 better than the Capital IQ Consensus of $1.49; revenues fell 0.7% year/year to $4.55 bln vs the $4.56 bln Capital IQ Consensus. Organic sales were down 1 percent due to lower net selling prices.
  • Co issues guidance for FY17, sees EPS at low end of $6.20-6.35 vs. $6.29 Capital IQ Consensus Estimate; sees FY17 revs similar to or slightly up Y/Y from $18.2 bln vs. $18.43 bln Capital IQ Consensus (down from +1-2%). Net sales and organic sales expected to be similar, or up slightly, year-on-year (prior assumption up 1 to 2 percent). Volumes anticipated to be up slightly, while net selling prices and product mix, combined, are expected to be down slightly. Input cost inflation of $200 to $300 million compared to the previous estimate of $150 to $250 million. The update is driven by higher assumptions for pulp costs. Cost savings of $425 to $450 million from the company's FORCE program. The prior estimate was for savings of at least $400 million.
  • "Our second quarter results reflect a challenging environment. Nonetheless, we continue to manage our company with financial discipline, as we achieved $120 million of cost savings, improved working capital and returned more than $600 million to shareholders through dividends and share repurchases. We are focused on competing effectively in the near-term while we continue to execute our Global Business Plan strategies for long-term success."

>>> Caterpillar beats by $0.23, beats on revs; guides FY17 EPS above consensus,

Caterpillar beats by $0.23, beats on revs; guides FY17 EPS above consensus, raises revenue guidance above consensus (108.18)
  • Reports Q2 (Jun) earnings of $1.49 per share, excluding non-recurring items, $0.23 better than the Capital IQ Consensus of $1.26; revenues rose 9.6% year/year to $11.33 bln vs the $10.96 bln Capital IQ Consensus.
  • As a result of increased demand across many end markets and disciplined cost control, Caterpillar is raising its 2017 outlook. Some risks remain in the outlook, including weakness in the Middle East and Latin America, as well as geopolitical and commodity risk
  • Co issues upside guidance for FY17, sees EPS of $5.00 vs. $4.32 Capital IQ Consensus Estimate
  • Meanwhile, the co raised its FY17 sales guidance to $42-44 bln vs. $40.74 bln Capital IQ Consensus Estimate, up from $38-41 bln, which was given in April 2017
Back to the quarter...
  • The 10% in increase in YoY sales was primarily due to higher sales volume, with the largest increase in Construction Industries mostly due to higher end-user demand for construction equipment
  • Sales volume for Resource Industries increased due to improved end-user demand for aftermarket parts and the favorable impact of changes in dealer inventories. Energy & Transportation's sales were higher mostly due to increased demand for aftermarket parts for reciprocating engines. Favorable price realization in Construction Industries also contributed to the sales improvement. The unfavorable impact of currency was mostly the result of a weaker euro and British pound. Financial Products' segment revenues were about fla
  • Sales increased in Asia/Pacific, North America and Latin America, and were about flat in EAME
  • Caterpillar's financial position continued to strengthen. Machinery, Energy & Transportation operating cash flow was $2.0 billion during the quarter, and ME&T's debt-to-capital ratio improved to 38.6 percent, compared with 41.7% at the end of the first quarter of 2017

>>> US Early premarket gappers

Early premarket gappers
Gapping up:
  • GNCA +7.2%, CLLS +5.2%, BIIB +4.5%, ACRX +4.1%, CNC +3.3%, RMBS+2.8%, CDNS +2.7%, JCP +2.4%, PHM +2.4%, TEAR +2.1%, ST +2.1%,SWFT +1.9%, MC +1.8%, KORS +1.7%, UTX +1.5%, JD +1.3%, AMD +1%,GRFS +0.8%, DD +0.8%, AVY +0.8%, SVU +0.6%, MBRX +0.5%
Gapping down:
  • TISI -20.8%, NVAX -18.5%, SANM -9.9%, FTI -8.2%, CLB -6.1%, CLB-6.1%, LOGI -5.3%, CRY -4.6%, EDU -4.3%, INCY -3.8%, HSII -2.9%,GOOG -2.7%, APC -2.7%, MU -2.6%, HXL -1.4%, SLNO -1.2%, SRPT -1%,WWD -0.6

>>> General Motors beats by $0.17, misses on revs; reaffirms FY17 EPS guidance

General Motors beats by $0.17, misses on revs; reaffirms FY17 EPS guidance (35.82)
  • Reports Q2 (Jun) earnings of $1.89 per share, excluding non-recurring items, $0.17 better than the Capital IQ Consensus of $1.72; revenues fell 1.1% year/year to $36.98 bln vs the $37.67 bln Capital IQ Consensus, driven primarily by decreased wholesale volumes in North America partially offset by strong mix and continued growth of GM Financial.
  • Global deliveries were flat Y-O-Y, driven primarily by the strategic reduction of less profitable daily rental sales in North America offset by increased volumes in GMSA due to the strength of the Chevrolet brand. Q2 market share is flat Y-O-Y, driven primarily by our strategy to reduce volumes into the daily-rental channel in GMNA offset by increased share in GMSA.
  • GM delivered 725,000 total vehicles in the United States, driven by a 24-percent increase in retail crossover sales. The Q2 crossover results are the best in GM history. NA EBIT $3.5 bln from $3.7 bln; Improved mix and cost efciencies largely ofset lower volumes, price and FX, and drove strong EBIT-adjusted and an EBIT-adjusted margin of 12.2 percent. In China, GM deliveries of 852,000 vehicles set a second-quarter record, up 1.6 percent compared to Q2 2016. Strong sales of Cadillac and Baojun vehicles led the way, up 62 percent and 66 percent, respectively.
  • Co reaffirms guidance for FY17, sees EPS of $6.00-6.50, excluding non-recurring items, vs. $6.08 Capital IQ Consensus, with adj. EBIT and rev greater to or equal 2016 levels.
  • "Strong results in North America and China, solid improvement in South America and continued growth of GM Financial drove another strong quarter. With an aggressive launch cadence still ahead this year, we are on track to meet our fnancial commitments for 2017."

(Bernstein) Apple PT Raised to $170, Buy On Any 3Q Weakness

Apple PT Raised to $170, Buy On Any 3Q Weakness: Bernstein

Apple PT raised to $170 from $160 by Bernstein analyst Toni Sacconaghi (outperform) ahead of FY3Q earnings scheduled for Aug. 1, saying that investors should use any weakness after results to add to positions.
  • Sees potential for “very weak” FY4Q guidance, with revenue guidance potentially $6b-$10b below Street expectations
    • Bernstein ests. FY4Q revenue at $42.7b vs Bloomberg consensus est. of $49.4b and notes that many analysts haven’t yet lowered ests. to factor in a delay for iPhone 8 models
  • Says weak guidance unlikely to matter unless iPhone 8 availability is pushed out past early November, in which case some customers may switch away from the iPhone
  • Says weakness after results would be a buying opportunity, given large installed base for iPhone 8 cycle and attractive valuation
  • Raises FY18 EPS est. to $10.79 to reflect an increase in iPhone ASPs and pushed out iPhone unit sales from 2H